Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease

[1]  P. Musto,et al.  Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? , 2022, Frontiers in Oncology.

[2]  M. Petrie,et al.  Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure , 2021, Clinical science.

[3]  T. Hibi,et al.  Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study , 2020, Intestinal research.

[4]  C. Deswarte,et al.  High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers. , 2020, Blood Advances.

[5]  J. Tardif,et al.  High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. , 2020, Blood advances.

[6]  N. Enomoto,et al.  Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8 , 2020, Intestinal research.

[7]  L. Bullinger,et al.  Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis , 2020, Haematologica.

[8]  D. Spencer,et al.  Inflammatory Cytokines Promote Clonal Hematopoiesis with Specific Mutations in Ulcerative Colitis Patients. , 2019, Experimental hematology.

[9]  Xin Wang,et al.  Risk of malignancy in Behcet disease , 2019, Medicine.

[10]  D. Steensma.  Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Blood advances.

[11]  S. Mustjoki,et al.  Clonal hematopoiesis in patients with rheumatoid arthritis , 2018, Blood Cancer Journal.

[12]  R. Bejar,et al.  Clonal Hematopoiesis in Aging , 2018, Current Stem Cell Reports.

[13]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[14]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[15]  Max Jan,et al.  Clonal hematopoiesis. , 2017, Seminars in hematology.

[16]  Xia Li,et al.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.

[17]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[18]  Queiroz,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  R. Arceci.  Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes , 2011 .

[20]  Eun Soo Kim,et al.  Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers , 2009, The American Journal of Gastroenterology.

[21]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[22]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.